TAVNEOS
- Product NDC
- 73556-168
- 11-digit product format
- 735560168
- Labeler code
- 73556
- Product ID
- 73556-168_55ca1a31-6002-420e-b804-8a5137df45d4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- avacopan
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- ChemoCentryx, Inc.
- Application
- NDA214487
- Marketing category
- NDA
- Marketing start
- 2021-10-18
- Substance
- AVACOPAN
- Active strength
- 10 mg/1
- Pharmacologic classes
- Complement 5a Receptor Antagonist [EPC], Complement 5a Receptor Antagonists [MoA], Cytochrome P450 3A4 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TAVNEOS
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AVACOPAN | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O880NM097T |
| Rxcui | 2572105, 2572111 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 73556-168 | TAVNEOS (AVACOPAN) CAPSULE [CHEMOCENTRYX, INC.] | 12 | Current NDC, Legacy NDC, 6 package rows | 20241215_c93cbc0b-29a3-46a5-9c85-41815ea5cf4a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 73556-168-01 | 73556016801 | 1 BOTTLE, PLASTIC in 1 CARTON (73556-168-01) / 180 CAPSULE in 1 BOTTLE, PLASTIC | 2021-10-18 | 0000-00-00 | No | No | Current |
| 73556-168-02 | 73556016802 | 1 BOTTLE, PLASTIC in 1 CARTON (73556-168-02) / 30 CAPSULE in 1 BOTTLE, PLASTIC | 2021-10-18 | 0000-00-00 | No | No | Current |
| 73556-168-96 | 73556016896 | 1 BOTTLE, PLASTIC in 1 CARTON (73556-168-96) / 30 CAPSULE in 1 BOTTLE, PLASTIC | 2021-10-18 | | Yes | No | Historical |